Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Product news (13 February 2010)

Accessing SPCs

SPCs for medicines are available online

SPC changes

Herceptin

Herceptin (trastuzumab; Roche) is now indicated, in combination with capecitabine or 5-fluorouracil and cisplatin, for the treatment of patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction and who have not received prior anti-cancer treatment for their metastatic disease.

For this indication Herceptin should be administered as an initial loading dose of 8mg/kg followed by 6mg/kg three weeks later and then 6mg/kg repeated at three-weekly intervals administered as infusions.

Orencia

Orencia (abatacept; Bristol-Myers Squibb) is now licensed, in combination with methotrexate, for the treatment of moderate to severe active polyarticular juvenile idiopathic arthritis in patients of six years of age or older who have had an insufficient response to other disease-modifying antirheumatic drugs, including methotrexate.

The recommended dose for patients aged six to 17 years  is 10mg/kg in children weighing less than 75kg.

For those weighing more than 75kg the adult dosing regimen should be followed, to a maximum dose of 1,000mg.

Prescription products

Dorzolamide

Dorzolamide eye drops 2 per cent are now available from Teva.

Net price:

1 x 5ml bottle, £6.33

Lercanidipine

Lercanidipine film-coated tablets are now available from Teva.

Net price:

28 x 10mg, £5.70
28 x 20mg, £10.82

Discontinued products

Beclazone

All strengths of Beclazone (beclometasone diproprionate) pressurised metered dose inhalers will be discontinued by Teva on 31 March 2010.

Further information from Teva medical information department on 020 7540 7117.

Counter products

Calci-plus

Calci-plus, a calcium carbonate, vitamin D3 and magnesium formulation is now available from Forum Health.

RRP:

1 x 30 tablets, £4.99

Legal category:

GSL

Citation: The Pharmaceutical Journal URI: 10996261

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.